| 000 | 01644 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250513112632.0 | ||
| 264 | 0 | _c19970320 | |
| 008 | 199703s 0 0 eng d | ||
| 022 | _a0161-5890 | ||
| 024 | 7 |
_a10.1016/s0161-5890(96)00077-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMiller, C G | |
| 245 | 0 | 0 |
_aTwo chemotactic factors, C5a and MIP-1alpha, dramatically alter the mortality from zymosan-induced multiple organ dysfunction syndrome (MODS): C5a contributes to MODS while MIP-1alpha has a protective role. _h[electronic resource] |
| 260 |
_bMolecular immunology _cOct 1996 |
||
| 300 |
_a1135-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aChemical and Drug Induced Liver Injury |
| 650 | 0 | 4 | _aChemokine CCL3 |
| 650 | 0 | 4 | _aChemokine CCL4 |
| 650 | 0 | 4 |
_aChemotactic Factors _xpharmacology |
| 650 | 0 | 4 |
_aComplement C5a _xpharmacology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeart Diseases _xchemically induced |
| 650 | 0 | 4 |
_aLiver Diseases _xdrug therapy |
| 650 | 0 | 4 |
_aLung Diseases _xchemically induced |
| 650 | 0 | 4 |
_aLymphatic Diseases _xchemically induced |
| 650 | 0 | 4 |
_aMacrophage Inflammatory Proteins _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Knockout |
| 650 | 0 | 4 |
_aMultiple Organ Failure _xchemically induced |
| 650 | 0 | 4 | _aSyndrome |
| 650 | 0 | 4 |
_aZymosan _xagonists |
| 700 | 1 | _aCook, D N | |
| 700 | 1 | _aKotwal, G J | |
| 773 | 0 |
_tMolecular immunology _gvol. 33 _gno. 14 _gp. 1135-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0161-5890(96)00077-6 _zAvailable from publisher's website |
| 999 |
_c9035780 _d9035780 |
||